3-Chloro-PCP: Difference between revisions
Content deleted Content added
No edit summary |
Altered title. Added the cs1 style template to denote Vancouver ("vanc") citation style, because references contain "vauthors" attribute to specify the list of authors. |
||
| (4 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{cs1 config|name-list-style=vanc}} |
|||
{{drugbox |
{{drugbox |
||
| drug_name = 3-Chloro-PCP |
| drug_name = 3-Chloro-PCP |
||
| image = 3 |
| image = 3-Chloro-PCP.svg |
||
| legal_CA = Schedule I |
| legal_CA = Schedule I |
||
| legal_UK = Class B |
| legal_UK = Class B |
||
| Line 7: | Line 9: | ||
| C = 17 | H = 24 | Cl = 1 | N = 1 |
| C = 17 | H = 24 | Cl = 1 | N = 1 |
||
| IUPAC_name = 1-[1-(3-chlorophenyl)cyclohexyl]piperidine |
| IUPAC_name = 1-[1-(3-chlorophenyl)cyclohexyl]piperidine |
||
| CAS_number_Ref = {{cascite|correct|CAS}} |
|||
| CAS_number = 2201-32-3 |
| CAS_number = 2201-32-3 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = BG2WV34L9L |
|||
| ChemSpiderID = |
| ChemSpiderID = |
||
| PubChem = 125502037 |
| PubChem = 125502037 |
||
| Line 15: | Line 20: | ||
}} |
}} |
||
'''3-Chloro-PCP''' ('''3'-Cl-PCP''') is a recreational [[designer drug]] from the [[arylcyclohexylamine]] family, with [[dissociative]] effects. It has comparable potency to [[phencyclidine]] but with a slightly different effects profile, being somewhat more potent as an [[NMDA antagonist]] but around the same potency as a [[dopamine reuptake inhibitor]].<ref name="pmid33633599">{{cite journal | vauthors = Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F | title = Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach | journal = Frontiers in Psychiatry | volume = 11 | issue = | pages = 632405 | date = 2020 | pmid = 33633599 | pmc = 7900492 | doi = 10.3389/fpsyt.2020.632405 | doi-access = free }}</ref> It was first identified in Slovenia in December 2020,<ref>{{cite web | url = https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/3Cl-PCP-ID-2201-20_report.pdf | title = Analytical Report. 3Cl-PCP (C17H24ClN). |
'''3-Chloro-PCP''' ('''3'-Cl-PCP''') is a recreational [[designer drug]] from the [[arylcyclohexylamine]] family, with [[dissociative]] effects. It has comparable potency to [[phencyclidine]] but with a slightly different effects profile, being somewhat more potent as an [[NMDA antagonist]] but around the same potency as a [[dopamine reuptake inhibitor]].<ref name="pmid33633599">{{cite journal | vauthors = Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F | title = Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach | journal = Frontiers in Psychiatry | volume = 11 | issue = | pages = 632405 | date = 2020 | pmid = 33633599 | pmc = 7900492 | doi = 10.3389/fpsyt.2020.632405 | doi-access = free }}</ref> It was first identified in Slovenia in December 2020,<ref>{{cite web | url = https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/3Cl-PCP-ID-2201-20_report.pdf | title = Analytical Report. 3Cl-PCP (C17H24ClN). 1-[1-(3-chlorophenyl)cyclohexyl]piperidine. | work = National Forensic Laboratory | location = Slovenia }}</ref> and was made illegal in Hungary in April 2021.<ref>{{cite web | url = https://ec.europa.eu/growth/tools-databases/tris/index.cfm/en/search/?trisaction=search.detail&year=2021&num=225&dLang=EN | title = Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU | date = 30 December 2014 | work = Minister for Human Capacities }}</ref> |
||
== See also == |
== See also == |
||
| Line 34: | Line 39: | ||
[[Category:Dissociative drugs]] |
[[Category:Dissociative drugs]] |
||
[[Category:Chloroarenes]] |
[[Category:Chloroarenes]] |
||
[[Category: |
[[Category:1-Piperidinyl compounds]] |
||
Latest revision as of 11:39, 13 January 2024
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H24ClN |
| Molar mass | 277.84 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Chloro-PCP (3'-Cl-PCP) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has comparable potency to phencyclidine but with a slightly different effects profile, being somewhat more potent as an NMDA antagonist but around the same potency as a dopamine reuptake inhibitor.[1] It was first identified in Slovenia in December 2020,[2] and was made illegal in Hungary in April 2021.[3]
See also
[edit]References
[edit]- ^ Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F (2020). "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach". Frontiers in Psychiatry. 11: 632405. doi:10.3389/fpsyt.2020.632405. PMC 7900492. PMID 33633599.
- ^ "Analytical Report. 3Cl-PCP (C17H24ClN). 1-[1-(3-chlorophenyl)cyclohexyl]piperidine" (PDF). National Forensic Laboratory. Slovenia.
- ^ "Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU". Minister for Human Capacities. 30 December 2014.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |